Inventor · disambiguated record
Zhen Zhu
Also filed as: ZHU ZHEN · Zhu zhen-yu
38 granted patents·30 pending applications·209 citations·filing 2000–2025
97Inventor score
Files withALLERGAN INC14BIOCHEMICS INC14EXXONMOBIL CHEMICAL PATENTS INC8CARTER STEPHEN G7BIOPHYSICS PHARMA INC3
Top patents by PatentIndex Score
68 records- 0193US6541504B1(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN SALES LLC·Filed 2002·Granted Apr 1, 2003·61 cites·18 claims
- 0291US8802085B2Compositions for topical treatment of medical conditions including wounds and inflammationBIOCHEMICS INC·Filed 2012·Granted Aug 12, 2014·8 cites·22 claims
- 0391US8343486B2Methods and compositions for topical treatment of medical conditions including wounds and inflammationBIOCHEMICS INC·Filed 2009·Granted Jan 1, 2013·10 cites·16 claims
- 0489US9278233B2Methods and compositions for tattoo removalCARTER STEPHEN G·Filed 2009·Granted Mar 8, 2016·7 cites·19 claims
- 0588US10322077B2Methods and compositions for tattoo removalBIOCHEMICS INC·Filed 2016·Granted Jun 18, 2019·4 cites·17 claims
- 0688US8367122B2Control of blood vessel physiology to treat skin disordersBIOCHEMICS INC·Filed 2009·Granted Feb 5, 2013·5 cites·18 claims
- 0788US7060844B2(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN INC·Filed 2003·Granted Jun 13, 2006·29 cites·3 claims
- 0887US10624867B2Transdermally-delivered combination drug therapy for painBIOCHEMICS INC·Filed 2018·Granted Apr 21, 2020·5 cites·12 claims
- 0987US8614234B2Compounds as tyrosine kinase modulatorsGUO XIALING·Filed 2010·Granted Dec 24, 2013·10 cites·26 claims
- 1084US11446257B2Transdermal drug delivery systemBIOPHYSICS PHARMA INC·Filed 2019·Granted Sep 20, 2022·2 cites·22 claims
- 1184US9566256B2Transdermal drug delivery using an osmolyte and vasoactive agentCARTER STEPHEN G·Filed 2009·Granted Feb 14, 2017·7 cites·73 claims
- 1284US8906944B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2012·Granted Dec 9, 2014·8 cites·4 claims
- 1382US8367664B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2007·Granted Feb 5, 2013·3 cites·11 claims
- 1481US8354116B2Bifunctional synthetic moleculesBIOCHEMICS INC·Filed 2007·Granted Jan 15, 2013·4 cites·4 claims
- 1581US6610907B1Cotton leaf curl virus (CLCuV) promoter and its useINST GENETICS CAS·Filed 2000·Granted Aug 26, 2003·28 cites·9 claims
- 1680US9328103B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2013·Granted May 3, 2016·3 cites·7 claims
- 1779US8809534B2Compounds as tyrosine kinase modulatorsGUO XIALING·Filed 2010·Granted Aug 19, 2014·3 cites·4 claims
- 1878US12319942B2Use of mutant of immunoglobulin degrading enzyme IdeESHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2024·Granted Jun 3, 2025·0 cites·14 claims
- 1978US8877923B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2012·Granted Nov 4, 2014·2 cites·3 claims
- 2077US9340555B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2014·Granted May 17, 2016·1 cites·3 claims
- 2176US11441023B2Polyethylene films and methods of making the sameEXXONMOBIL CHEMICAL PATENTS INC·Filed 2018·Granted Sep 13, 2022·1 cites·24 claims
- 2276US9725433B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2016·Granted Aug 8, 2017·1 cites·10 claims
- 2376US2025120907A1Transmucosal Drug Delivery SystemMASIZ JOHN J·Filed 2024·Application pending·0 cites
- 2475US9561174B2Ibuprofen for topical administrationCARTER STEPHEN G·Filed 2012·Granted Feb 7, 2017·2 cites·12 claims
- 2574US12246098B2Trans-epithelial membrane drug delivery systemBIOPHYSICS PHARMA INC·Filed 2024·Granted Mar 11, 2025·0 cites·24 claims
- 2674US8865682B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2012·Granted Oct 21, 2014·1 cites·4 claims
- 2774US8338415B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsGUO XIALING·Filed 2007·Granted Dec 25, 2012·1 cites·6 claims
- 2873US9475801B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2015·Granted Oct 25, 2016·1 cites·15 claims
- 2972US11865217B2Transdermal drug delivery systemBIOPHYSICS PHARMA INC·Filed 2022·Granted Jan 9, 2024·0 cites·30 claims
- 3072US10537536B2Transdermal drug delivery using an osmolyte and vasoactive agentBIOCHEMICS INC·Filed 2015·Granted Jan 21, 2020·1 cites·18 claims
- 3167US9657005B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2014·Granted May 23, 2017·0 cites·1 claims
- 3266US9758509B2Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Sep 12, 2017·0 cites·1 claims
- 3366US2015099746A1Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3466US2010137443A1Ibuprofen for Topical AdministrationBIOCHEMICS INC·Filed 2009·Application pending·0 cites
- 3563US10221192B2Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2017·Granted Mar 5, 2019·0 cites·2 claims
- 3662US10751309B2Transdermal drug delivery using an osmolyte and vasoactive agentBIOCHEMICS INC·Filed 2016·Granted Aug 25, 2020·0 cites·25 claims
- 3762US2021259951A1Transmucosal Drug Delivery SystemMASIZ JOHN J·Filed 2021·Application pending·0 cites
- 3862US2020009095A1Ibuprofen for Topical AdministrationBIOCHEMICS INC·Filed 2019·Application pending·0 cites
- 3961US2013245538A1Control of Blood Vessel Physiology To Treat Skin DisordersBIOCHEMICS INC·Filed 2013·Application pending·0 cites
- 4061US2025268841A1Trans-Epithelial Membrane Drug Delivery SystemMASIZ JOHN J·Filed 2025·Application pending·0 cites
- 4160US2025257346A1Use of mutant of immunoglobulin degrading enzyme ideeSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 4258US2006160911A1Process for making polyurethane and polyisocyanurate foams using mixtures of a hydrofluorocarbon and methyl formate as a blowing agentHONEYWELL INT INC·Filed 2006·Application pending·0 cites
- 4357US2016235846A1Control of Blood Vessel Physiology To Treat Skin DisordersBIOCHEMICS INC·Filed 2016·Application pending·0 cites
- 4456US2016355527A1Compounds as tyrosine kinase modulatorsALLERGAN INC·Filed 2016·Application pending·0 cites
- 4555US2017095433A1Ibuprofen for Topical AdministrationBIOCHEMICS INC·Filed 2016·Application pending·0 cites
- 4654US2025099557A1Antibiotic pharmaceutical composition capable of subcutaneous administrationSHANGHAI BAO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 4754US2006013866A1Transdermal drug delivery formulations with optimal amounts of vasodilators thereinCARTER STEPHEN G·Filed 2004·Application pending·0 cites
- 4854US2005282870A1Peripherally-acting vasodilatorsCARTER STEPHEN G·Filed 2004·Application pending·0 cites
- 4954US2006062836A1Methods of device-assisted drug deliveryCARTER STEPHEN G·Filed 2004·Application pending·0 cites
- 5054US2006013769A1Transdermal drug delivery formulations and method of determining optimal amounts of vasodilators thereinCARTER STEPHEN·Filed 2004·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zhen Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →